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VITAMIN D DEFICIENCY
Authors’ reply to Nussey
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clinical senior lecturer 4, N J Shaw consultant paediatric endocrinologist 8
1Sheffield Children’s NHS Foundation Trust, Sheffield, UK; 2School of Medicine, University of Glasgow, Glasgow, UK; 3Great Ormond Street Hospital,
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We read Professor Nussey’s response to our position statement
with interest.1 2 We are not a committee but a current
comprehensive group of clinicians who manage children with
bone disease in the UK. Our opinions are based on our combined
clinical experience of vitamin D deficiency in infants, children,
and adolescents across the UK. Our statement was a concise
expression of our position rather than an exposition of the
evidence. However, careful consideration of the extant literature
underpins our statement (although we acknowledge the paucity
of studies that examine clinical outcomes in relation to serum
25-hydroxyvitamin D3 (25-(OH)D3) concentrations).
Our cut-off value for 25-(OH)D3 (25 nmol/L) is that used by
the National Institute for Health and Clinical Excellence for
deficiency. It is based on systematic reviews undertaken by the
Cochrane Collaboration, the Scientific Advisory Committee on
Nutrition, the Institute of Medicine, and the Department of
Health for “low vitamin D status” (endorsed in the recent letter
from the UK chief medical officers).3 Nonetheless, rather than
this value (which depends partly on the laboratory method used)
alone determining the development of rickets, other crucial
factors need to be taken into account, including low serum
phosphate or low dietary intake of calcium resulting in an
increase in serum parathyroid hormone. In contrast to the adult
autopsy data cited, Edouard and colleagues found no evidence
of defects of bone mineralisation in bone biopsies from 37
childrenwith serum 25-(OH)D3 concentrations of 13-50 nmol/L.
4
It is true that we have not looked at the important question of
whether current recommended doses of vitamin D raise serum
25-(OH)D3 concentrations adequately, but there is not yet an
agreed definition of “adequate.”
Nussey provides no references to support the statement that a
few children with rickets have “several” fractures. The evidence
suggests that, if fracture occurs in a mobile child with rickets,
a single fracture is the norm. The national diet and nutrition
survey showed that up to 30% of South Asian toddlers in the
UK have a 25-(OH)D3 concentration less than 25 nmol/L.
5
Vitamin D status in infants in this group is probably the same
or even lower. If serum 25-(OH)D3 less than 25 nmol/L were
associated with fragility fractures, we would expect to see
hundreds of cases of fractures of ribs or proximal humeruses
captured on the thousands of chest radiographs performed for
indications such as bronchiolitis each year. This is not our
experience. We also know that the prevalence of clinical signs
of rickets is far lower than the incidence of deficiency
(<1/1000).6
We stand by our original statement and trust that the guidance
provided will be useful for clinicians managing children with
vitamin D related problems.
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